Stay updated on VAY736 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the VAY736 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the VAY736 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe study record for Novartis’s VAY736 idiopathic pulmonary fibrosis trial is now displayed, with details on its design, participants, outcomes, locations, and shared study documents.SummaryDifference62%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page displays the full NCT03287414 record for Novartis’s VAY736 study in idiopathic pulmonary fibrosis, including its terminated status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference65%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and its related documents on this URL.SummaryDifference19%

Stay in the know with updates to VAY736 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAY736 in Idiopathic Pulmonary Fibrosis Clinical Trial page.